NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

That’s what everyone said about high impact peer reviewed publication (JAMA) and TLD. It didn’t build excitement amongst investor community. MIA also is a strong indication UK approvals are coming, but the street did not react.

As UK approvals come through, shorts will find a way to create negative spin around reimbursement and manufacturing. They always move on to next. How will NWBO management defend itself or convince investors? They haven’t shown they are capable of doing this time and again at important milestones including in the last year or two.